Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pronzato

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Anticancer Research|September 1, 1992
Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMFE Campora, P Pronzato, D Amoroso, et al.
American Journal of Clinical Oncology|October 1, 1987
Sequential administration of cyclophosphamide, methotrexate, 5-fluorouracil, and folinic acid as salvage treatment in metastatic breast cancerP Pronzato, D Amoroso, A Ardizzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized studyG Bertelli, M Venturini, L Del Mastro, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 23, 2005
Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral bloodS Roncella, P Ferro, B Bacigalupo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo GroupL Del Mastro, M Venturini, R Lionetto, et al.
Medical Oncology (Northwood, London, England)|December 6, 2013
A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practiceS Barni, V Lorusso, M Giordano, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 10, 2006
Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumorsS Roncella, P Ferro, B Bacigalupo, et al.
Tumori|January 16, 1998
A randomized trial of chemotherapy with or without estrogenic recruitment in locally advanced breast cancer. North-West Oncology Group (GONO) Study, ItalyE Baldini, G Gardin, P Giannessi, et al.
Recenti Progressi in Medicina|November 7, 2001
[Prevalence of anemia in oncologic patients treated with chemotherapy. Italian survey at the national level]G Bernardo, M Aglietta, D Amadori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)P F Conte, E Baldini, G Gardin, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Anticancer Research|September 1, 1992
Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMFE Campora, P Pronzato, D Amoroso, et al.
American Journal of Clinical Oncology|October 1, 1987
Sequential administration of cyclophosphamide, methotrexate, 5-fluorouracil, and folinic acid as salvage treatment in metastatic breast cancerP Pronzato, D Amoroso, A Ardizzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized studyG Bertelli, M Venturini, L Del Mastro, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 23, 2005
Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral bloodS Roncella, P Ferro, B Bacigalupo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo GroupL Del Mastro, M Venturini, R Lionetto, et al.
Medical Oncology (Northwood, London, England)|December 6, 2013
A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practiceS Barni, V Lorusso, M Giordano, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 10, 2006
Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumorsS Roncella, P Ferro, B Bacigalupo, et al.
Tumori|January 16, 1998
A randomized trial of chemotherapy with or without estrogenic recruitment in locally advanced breast cancer. North-West Oncology Group (GONO) Study, ItalyE Baldini, G Gardin, P Giannessi, et al.
Recenti Progressi in Medicina|November 7, 2001
[Prevalence of anemia in oncologic patients treated with chemotherapy. Italian survey at the national level]G Bernardo, M Aglietta, D Amadori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)P F Conte, E Baldini, G Gardin, et al.
Pageof 13